Search

GE HealthCare Technologies

Suletud

SektorTervishoid

63.47 -0.91

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

63.48

Max

64.62

Põhinäitajad

By Trading Economics

Sissetulek

163M

574M

Müük

164M

5.3B

P/E

Sektori keskmine

15.866

56.597

Aktsiakasum

1.13

Dividenditootlus

0.2

Kasumimarginaal

10.84

Töötajad

54,000

EBITDA

198M

953M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+23.07% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.20%

2.18%

Järgmine tulemuste avaldamine

28. okt 2026

Järgmine dividendimakse kuupäev

13. nov 2026

Järgmine aktsia dividendi kuupäev (ex-date)

23. okt 2026

Turustatistika

By TradingEconomics

Turukapital

3.3B

31B

Eelmine avamishind

64.38

Eelmine sulgemishind

63.47

Uudiste sentiment

By Acuity

30%

70%

54 / 339 Pingereas Healthcare

GE HealthCare Technologies Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. sept 2026, 22:51 UTC

Shares of GE Healthcare Technologies rose in after-market hours, despite broader market uncertainties following a notable decline in the NY Empire State Manufacturing Index.

14. sept 2026, 23:31 UTC

GE Healthcare Technologies shares are higher in after-market trading, despite unusual activity earlier in the session and remaining below the 20-day moving average.

11. sept 2026, 20:08 UTC

GE Healthcare Technologies is lower today, continuing a seven-session decline. The stock is trading significantly below its 20-day moving average.

10. sept 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading following Thursday's close, despite being below the 20-day moving average and recent declines.

9. sept 2026, 19:56 UTC

GE Healthcare Technologies shares are lower, continuing a five-session decline amid broader market pressures and rising crude oil prices raising inflation concerns.

8. sept 2026, 23:01 UTC

GE Healthcare Technologies shares are higher in after-market trading, advancing modestly since Tuesday's close despite being below its 20-day moving average.

4. sept 2026, 20:08 UTC

Shares of GE Healthcare Technologies are lower today, continuing a decline since Thursday's close amid broader market selling pressure following a strong jobs report.

3. sept 2026, 20:07 UTC

News

GE Healthcare Technologies received CE Mark approval for its Photonova Spectra CT system, but shares are trading lower during Thursday's session.

2. sept 2026, 23:06 UTC

GE Healthcare Technologies shares are higher in after-market trading, reflecting a modest gain since Wednesday's close, despite settling lower earlier in the session.

1. sept 2026, 23:01 UTC

GE Healthcare Technologies shares are higher in after-market hours, reflecting a recovery after a week of lower closes. No specific news was identified.

31. aug 2026, 19:46 UTC

GE Healthcare Technologies is lower amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh, raising interest rate hike expectations.

28. aug 2026, 22:06 UTC

GE Healthcare Technologies shares are higher in after-market hours, despite no specific news and recent declines in the last five sessions.

27. aug 2026, 23:02 UTC

Shares of GE Healthcare Technologies Inc. are lower in after-market hours, continuing a trend of declines over the past four sessions.

26. aug 2026, 23:06 UTC

GE Healthcare Technologies shares are lower in after-market trading, continuing a downward trend observed over the past four sessions amid persistent inflationary pressures.

25. aug 2026, 19:46 UTC

GE Healthcare Technologies is trading lower today, reflecting a modest decline since Monday's close. The stock remains near the upper end of its one-month range.

24. aug 2026, 23:36 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting a slight increase since Monday's close and strong monthly performance.

19. aug 2026, 20:06 UTC

News

GE Healthcare Technologies appointed William Grogan as CFO, effective September 2026. BTIG reiterated its Buy rating with a $79 price target. Shares are higher since Tuesday's close.

18. aug 2026, 23:51 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, reaching above Tuesday's close despite elevated bond yields and ongoing inflation concerns.

17. aug 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading, reaching a notable increase while remaining above its 20-day moving average. No specific news was identified.

14. aug 2026, 19:46 UTC

GE Healthcare Technologies is trading roughly flat, with no specific news identified. Shares peaked earlier but have since settled back down.

13. aug 2026, 23:46 UTC

GE Healthcare Technologies shares declined in after-market trading, reflecting a slight drop since Thursday's close. The stock remained above its 20-day moving average.

12. aug 2026, 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

11. aug 2026, 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

10. aug 2026, 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

7. aug 2026, 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

6. aug 2026, 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

5. aug 2026, 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

4. aug 2026, 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3. aug 2026, 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31. juuli 2026, 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

Võrdlus sarnastega

Hinnamuutus

GE HealthCare Technologies Prognoos

Hinnasiht

By TipRanks

23.07% tõus

12 kuu keskmine prognoos

Keskmine 79.071 USD  23.07%

Kõrge 92 USD

Madal 70 USD

Põhineb 14 Wall Streeti analüütiku instrumendi GE HealthCare Technologies 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

9

Osta

5

Hoia

0

Müü

Sentiment

By Acuity

54 / 339 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
help-icon Live chat